Plegridy 94 mcg (Peginterferon Beta-1a KIT) 94 MCG

Plegridy 94 mcg is a subcutaneous injection used for managing specific medical conditions. This medication, containing peginterferon beta-1a, is designed for convenient self-administration.

Strength

94 MCG

Pack Size

0.5ML SYRINGE OR PEN AND 0.5 ML SYRINGE OR PEN

Manufacturer / TM Owner

BIOGEN CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Plegridy 94 mcg is primarily used for the treatment of relapsing forms of a particular condition. It works by modulating the immune system to reduce inflammation and slow disease progression. Patients often wonder, 'What is Plegridy used for?' This medication is typically prescribed to help manage symptoms and improve quality of life.

Side Effects

Common effects of Plegridy 94 mcg may include injection site reactions, flu-like symptoms, and fatigue. Some users also report headaches and muscle aches. These effects are generally mild to moderate and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Plegridy 94 mcg should be handled with care, following the prescribed administration guidelines. It is important to store the medication properly and to use it as directed by a healthcare professional. Patients should be aware of potential allergic reactions and seek medical advice if severe symptoms occur.

Avoid Interactions

Plegridy 94 mcg may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of Plegridy.

Frequently Asked Questions

Plegridy 94 mcg is used to manage relapsing forms of a specific condition by modulating the immune system.

Plegridy 94 mcg is administered subcutaneously, typically via a pre-filled syringe or pen.

Common side effects include injection site reactions, flu-like symptoms, fatigue, headaches, and muscle aches.

Plegridy 94 mcg may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Plegridy 94 mcg should be stored according to the manufacturer's guidelines, typically in a refrigerator.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.